Tobacco giant turns into a health business

Tobacco giant Philip Morris plans to source more than half of its revenue from smokeless products by 2025. But their "beyond nicotine" strategy is even more radical than this. Philippe Morris is actively moving into the health space: In less than 2 months, the company has acquired the Danish company Fertin Pharma, the drug company OtiTopic, and has taken a major stake in Vectura.

Want to read more?

Subscribe to christophejauquet.com to keep reading this exclusive post.

Subscribe Now